Kurt F. Somerville’s Teva Pharmaceuticals TEVA Stock Holding History

Kurt F. Somerville’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,600	Closed	-$304K	–	113
2016 Q3	$304K	Hold	6,600	–	–	0.07%	94
2016 Q2	$332K	Hold	6,600	–	–	0.07%	91
2016 Q1	$354K	Hold	6,600	–	–	0.08%	88
2015 Q4	$433K	Hold	6,600	–	–	0.1%	82
2015 Q3	$373K	Hold	6,600	–	–	0.1%	86
2015 Q2	$390K	Hold	6,600	–	–	0.09%	88
2015 Q1	$411K	Sell	6,600 -500	-7%	-$29.1K	0.09%	90
2014 Q4	$408K	Buy	7,100 +2,600	+58%	+$145K	0.1%	93
2014 Q3	$241K	Hold	4,500	–	–	0.1%	93
2014 Q2	$236K	Sell	4,500 -10	-0.2%	-$511	0.09%	96
2014 Q1	$238K	Sell	4,510 -13,650	-75%	-$631K	0.09%	95
2013 Q4	$728K	Sell	18,160 -37,075	-67%	-$1.46M	0.28%	65
2013 Q3	$2.09M	Sell	55,235 -9,040	-14%	-$353K	0.83%	39
2013 Q2	$2.52M	Buy	+64,275	New	+$2.5M	1.06%	31

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Kurt F. Somerville's TEVA Position: Q4 2016 in Review

Kurt F. Somerville sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 6,600 shares — an estimated $304K sold.

Kurt F. Somerville first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $2.52M in Q2 2013. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Kurt F. Somerville reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Kurt F. Somerville sold 6,600 Teva Pharmaceuticals shares in Q4 2016, an estimated $304K.
Kurt F. Somerville first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Kurt F. Somerville's Teva Pharmaceuticals position peaked at $2.52M in Q2 2013.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Kurt F. Somerville's 13F filing for Q4 2016, filed 14 Feb 2017.